 This statistic displays the global inflammation and autoimmunity therapy market by condition based on the MAT (moving annual total) until the third quarter of 2015 (October 2014 to September 2015). In that year, the global gout therapy market was worth 1.3 billion U.S. dollars. Autoimmune diseases are defined as the body's own immune system attacks its own tissues which can cause inflammation 